PExA

0,23 SEK

-7,79%

Mindre end 1K følgere

PEXA B

Spotlight Stock Market

Medical Equipment & Services

Health Care

-7,79 %
-15,73 %
+13,07 %
+3,21 %
-29,69 %
+12,89 %
-42,48 %
-81,24 %
-89,24 %

PExA offers a patented, non-invasive technology to collect biomarkers from the small airways of the lung via exhaled air. The method is used globally by universities, hospitals, pharmaceutical companies, CROs and government agencies in the US and Europe, among others – in research on asthma, COPD, lung cancer, occupational exposure and pharmacokinetics. The company's goal is to enable earlier diagnosis and screening of lung diseases. PExA was founded in 2014 and is headquartered in Gothenburg.

Læs mere
Markedsværdi
27,93 mio. SEK
Aktieomsætning
48,97 t SEK
Omsætning
477,68 t
EBIT %
-1.322,21 %
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin

Omsætning mio.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
28.5
2026

Generalforsamling '26

28.8
2026

Delårsrapport Q2'26

6.11
2026

Delårsrapport Q3'26